相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Biological basis for functional cure of chronic hepatitis B
Maria G. Martinez et al.
JOURNAL OF VIRAL HEPATITIS (2019)
Non-viral Delivery of Zinc Finger Nuclease mRNA Enables Highly Efficient In Vivo Genome Editing of Multiple Therapeutic Gene Targets
Anthony Conway et al.
MOLECULAR THERAPY (2019)
Identification of preexisting adaptive immunity to Cas9 proteins in humans
Carsten T. Charlesworth et al.
NATURE MEDICINE (2019)
TALEN-Mediated Gene Editing of HBG in Human Hematopoietic Stem Cells Leads to Therapeutic Fetal Hemoglobin Induction
Christopher T. Lux et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2019)
A Facile Method for the Removal of dsRNA Contaminant from In Vitro-Transcribed mRNA
Markus Baiersdoerfer et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2019)
Recent advances in the development of HBV capsid assembly modulators
Bhavitavya Nijampatnam et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2019)
Establishment of knockout adult sea urchins by using a CRISPR-Cas9 system
Daming Liu et al.
DEVELOPMENT GROWTH & DIFFERENTIATION (2019)
A global scientific strategy to cure hepatitis B
Peter A. Revill et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2019)
A convenient method to generate and maintain poly(A)-encoding DNA sequences required for in vitro transcription of mRNA
Patrick Arbuthnot et al.
BIOTECHNIQUES (2019)
Serum Hepatitis B Virus RNA: A New Potential Biomarker for Chronic Hepatitis B Virus Infection
Shi Liu et al.
HEPATOLOGY (2019)
Serum hepatitis B core-related antigen (HBcrAg) correlates with covalently closed circular DNA transcriptional activity in chronic hepatitis B patients
Barbara Testoni et al.
JOURNAL OF HEPATOLOGY (2019)
High prevalence of Streptococcus pyogenes Cas9-reactive T cells within the adult human population
Dimitrios L. Wagner et al.
NATURE MEDICINE (2019)
Unbiased detection of CRISPR off-targets in vivo using DISCOVER-Seq
Beeke Wienert et al.
SCIENCE (2019)
Hepatitis B vaccine nonresponders Possible mechanisms and solutions
Tara Vinyette Saco et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2018)
Inhibition of hepatitis B virus replication via HBV DNA cleavage by Cas9 from Staphylococcus aureus
Yu Liu et al.
ANTIVIRAL RESEARCH (2018)
A Single Administration of CRISPR/Cas9 Lipid Nanoparticles Achieves Robust and Persistent In Vivo Genome Editing
Jonathan D. Finn et al.
CELL REPORTS (2018)
Optimization of a Degradable Polymer-Lipid Nanoparticle for Potent Systemic Delivery of mRNA to the Lung Endothelium and Immune Cells
James C. Kaczmarek et al.
NANO LETTERS (2018)
Dendrimer-Based Lipid Nanoparticles Deliver Therapeutic FAH mRNA to Normalize Liver Function and Extend Survival in a Mouse Model of Hepatorenal Tyrosinemia Type I
Qiang Cheng et al.
ADVANCED MATERIALS (2018)
Non-Viral CRISPR/Cas Gene Editing In Vitro and In Vivo Enabled by Synthetic Nanoparticle Co-Delivery of Cas9 mRNA and sgRNA
Jason B. Miller et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2017)
CIRCLE-seq: a highly sensitive in vitro screen for genome-wide CRISPR Cas9 nuclease off-targets
Shengdar Q. Tsai et al.
NATURE METHODS (2017)
RNAi-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBsAg
Christine I. Wooddell et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Hepatocytic expression of human sodium-taurocholate cotransporting polypeptide enables hepatitis B virus infection of macaques
Benjamin J. Burwitz et al.
NATURE COMMUNICATIONS (2017)
Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge
Norbert Pardi et al.
NATURE COMMUNICATIONS (2017)
ssAAVs containing cassettes encoding SaCas9 and guides targeting hepatitis B virus inactivate replication of the virus in cultured cells
Tristan Scott et al.
SCIENTIFIC REPORTS (2017)
Alpha-interferon treatment in hepatitis B
Aaron Shu Jeng Woo et al.
ANNALS OF TRANSLATIONAL MEDICINE (2017)
A non-viral CRISPR/Cas9 delivery system for therapeutically targeting HBV DNA and pcsk9 in vivo
Chao Jiang et al.
CELL RESEARCH (2017)
A Single Methylene Group in Oligoalkylamine-Based Cationic Polymers and Lipids Promotes Enhanced mRNA Delivery
Anita Jarzebinska et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
Polymer-Lipid Nanoparticles for Systemic Delivery of mRNA to the Lungs
James C. Kaczmarek et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
GRK5-Knockout Mice Generated by TALEN-Mediated Gene Targeting
Tsevelmaa Nanjidsuren et al.
ANIMAL BIOTECHNOLOGY (2016)
Efficacy and immunogenicity of unmodified and pseudouridine-modified mRNA delivered systemically with lipid nanoparticles in vivo
Kevin J. Kauffman et al.
BIOMATERIALS (2016)
Therapeutic efficacy in a hemophilia B model using a biosynthetic mRNA liver depot system
F. DeRosa et al.
GENE THERAPY (2016)
Experimental in vitro and in vivo models for the study of human hepatitis B virus infection
Lena Allweiss et al.
JOURNAL OF HEPATOLOGY (2016)
Progress With Developing Use of Gene Editing To Cure Chronic Infection With Hepatitis B Virus
Abdullah Ely et al.
MOLECULAR THERAPY (2016)
Poly(glycoamidoamine) Brushes Formulated Nanomaterials for Systemic siRNA and mRNA Delivery in Vivo
Yizhou Dong et al.
NANO LETTERS (2016)
Hepatitis B virus X protein identifies the Smc5/6 complex as a host restriction factor
Adrien Decorsiere et al.
NATURE (2016)
Targeted gene addition in human CD34+ hematopoietic cells for correction of X-linked chronic granulomatous disease
Suk See De Ravin et al.
NATURE BIOTECHNOLOGY (2016)
Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo
Hao Yin et al.
NATURE BIOTECHNOLOGY (2016)
Global epidemiology of hepatitis C virus infection: an up-date of the distribution and circulation of hepatitis C virus genotypes
Arnolfo Petruzziello et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
pEVL: A Linear Plasmid for Generating mRNA IVT Templates With Extended Encoded Poly(A) Sequences
Alexandra E Grier et al.
Molecular Therapy-Nucleic Acids (2016)
Sodium taurocholate cotransporting polypeptide inhibition efficiently blocks hepatitis B virus spread in mice with a humanized liver
Tasuku Nakabori et al.
SCIENTIFIC REPORTS (2016)
Human cellular CYBA UTR sequences increase mRNA translation without affecting the half-life of recombinant RNA transcripts
Mehrije Ferizi et al.
SCIENTIFIC REPORTS (2016)
Targeting hepatitis B virus cccDNA by CRISPR/Cas9 nuclease efficiently inhibits viral replication
Chunsheng Dong et al.
ANTIVIRAL RESEARCH (2015)
Efficient expression of stabilized mRNA PEG-peptide polyplexes in liver
S. T. Crowley et al.
GENE THERAPY (2015)
N1-methylpseudouridine-incorporated mRNA outperforms pseudouridine-incorporated mRNA by providing enhanced protein expression and reduced immunogenicity in mammalian cell lines and mice
Oliwia Andries et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes
Norbert Pardi et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Inhibition of hepatitis B virus by the CRISPR/Cas9 system via targeting the conserved regions of the viral genome
Xing Liu et al.
JOURNAL OF GENERAL VIROLOGY (2015)
Human Cytotoxic T Lymphocyte-Mediated Acute Liver Failure and Rescue by Immunoglobulin in Human Hepatocyte Transplant TK-NOG Mice
Takuro Uchida et al.
JOURNAL OF VIROLOGY (2015)
An AAVS1-Targeted Minigene Platform for Correction of iPSCs From All Five Types of Chronic Granulomatous Disease
Randall K. Merling et al.
MOLECULAR THERAPY (2015)
Sequence-engineered mRNA Without Chemical Nucleoside Modifications Enables an Effective Protein Therapy in Large Animals
Andreas Thess et al.
MOLECULAR THERAPY (2015)
Optimization of Lipid Nanoparticle Formulations for mRNA Delivery in Vivo with Fractional Factorial and Definitive Screening Designs
Kevin J. Kauffman et al.
NANO LETTERS (2015)
Homology-driven genome editing in hematopoietic stem and progenitor cells using ZFN mRNA and AAV6 donors
Jianbin Wang et al.
NATURE BIOTECHNOLOGY (2015)
Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells
Ayal Hendel et al.
NATURE BIOTECHNOLOGY (2015)
mRNA transfection of a novel TAL effector nuclease (TALEN) facilitates efficient knockout of HIV co-receptor CCR5
Ulrike Mock et al.
NUCLEIC ACIDS RESEARCH (2015)
Age-related immune clearance of hepatitis B virus infection requires the establishment of gut microbiota
Han-Hsuan Chou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Dual gRNAs guided CRISPR/Cas9 system inhibits hepatitis B virus replication
Jie Wang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus
Vyas Ramanan et al.
SCIENTIFIC REPORTS (2015)
CRISPR/Cas9 nickase-mediated disruption of hepatitis B virus open reading frame S and X
Madina Karimova et al.
SCIENTIFIC REPORTS (2015)
Messenger RNA-based therapeutics for the treatment of apoptosis-associated diseases
Akitsugu Matsui et al.
SCIENTIFIC REPORTS (2015)
The Chimpanzee Model for Hepatitis B Virus Infection
Stefan F. Wieland
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2015)
CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes
Puping Liang et al.
PROTEIN & CELL (2015)
Recent advances in vaccination of non-responders to standard dose hepatitis B virus vaccine
Saqib Walayat et al.
WORLD JOURNAL OF HEPATOLOGY (2015)
Genotypes and viral variants in chronic hepatitis B: A review of epidemiology and clinical relevance
Catherine M. N. Croagh et al.
WORLD JOURNAL OF HEPATOLOGY (2015)
TALEN-mediated genome editing: prospects and perspectives
David A. Wright et al.
BIOCHEMICAL JOURNAL (2014)
A mouse model for HBV immunotolerance and immunotherapy
Dan Yang et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2014)
Hepatitis B and D Viruses Exploit Sodium Taurocholate Co-transporting Polypeptide for Species-Specific Entry into Hepatocytes
Yi Ni et al.
GASTROENTEROLOGY (2014)
An Efficient Antiviral Strategy for Targeting Hepatitis B Virus Genome Using Transcription Activator-Like Effector Nucleases
Jieliang Chen et al.
MOLECULAR THERAPY (2014)
Poly(A)-tail profiling reveals an embryonic switch in translational control
Alexander O. Subtelny et al.
NATURE (2014)
CRISPR-Cas systems for editing, regulating and targeting genomes
Jeffry D. Sander et al.
NATURE BIOTECHNOLOGY (2014)
AAV-Mediated Delivery of Zinc Finger Nucleases Targeting Hepatitis B Virus Inhibits Active Replication
Nicholas D. Weber et al.
PLOS ONE (2014)
Involvement of the host DNA-repair enzyme TDP2 in formation of the covalently closed circular DNA persistence reservoir of hepatitis B viruses
Christian Koeniger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
HBeAg negative variants and their role in the natural history of chronic hepatitis B virus infection
Alexandra Alexopoulou et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Hepatitis B virus genotypes: Global distribution and clinical importance
Mustafa Sunbul
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Hepatitis B Virus Infection and Immunopathogenesis in a Humanized Mouse Model: Induction of Human-Specific Liver Fibrosis and M2-Like Macrophages
Moses T. Bility et al.
PLOS PATHOGENS (2014)
The CRISPR/Cas9 System Facilitates Clearance of the Intrahepatic HBV Templates In Vivo
Su-Ru Lin et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2014)
Targeting Hepatitis B Virus With CRISPR/Cas9
Christoph Seeger et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2014)
Chronic hepatitis B: Advances in treatment
Teresa Antonia Santantonio et al.
WORLD JOURNAL OF HEPATOLOGY (2014)
Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity
F. Ann Ran et al.
CELL (2013)
A conformational heparan sulfate binding site essential to infectivity overlaps with the conserved hepatitis B virus A-determinant
Camille Sureau et al.
HEPATOLOGY (2013)
Modeling the proton sponge hypothesis: examining proton sponge effectiveness for enhancing intracellular gene delivery through multiscale modeling
Eric C. Freeman et al.
JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION (2013)
The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus
Tassilo Volz et al.
JOURNAL OF HEPATOLOGY (2013)
Inactivation of Hepatitis B Virus Replication in Cultured Cells and In Vivo with Engineered Transcription Activator-Like Effector Nucleases
Kristie Bloom et al.
MOLECULAR THERAPY (2013)
Biodegradable Lipids Enabling Rapidly Eliminated Lipid Nanoparticles for Systemic Delivery of RNAi Therapeutics
Martin A. Maier et al.
MOLECULAR THERAPY (2013)
High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity
Vikram Pattanayak et al.
NATURE BIOTECHNOLOGY (2013)
High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells
Yanfang Fu et al.
NATURE BIOTECHNOLOGY (2013)
Targeted genome modification of crop plants using a CRISPR-Cas system
Qiwei Shan et al.
NATURE BIOTECHNOLOGY (2013)
Multiplex Genome Engineering Using CRISPR/Cas Systems
Le Cong et al.
SCIENCE (2013)
Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo
Muthusamy Jayaraman et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2012)
Impact of the implementation of a vaccination strategy on hepatitis B virus infections in China over a 20-year period
Zhuanbo Luo et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2012)
In vivo genome editing using a high-efficiency TALEN system
Victoria M. Bedell et al.
NATURE (2012)
A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity
Martin Jinek et al.
SCIENCE (2012)
Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus
Huan Yan et al.
ELIFE (2012)
Direct Acting Antivirals for the Treatment of Chronic Viral Hepatitis
Peter Karayiannis
SCIENTIFICA (2012)
Nucleoside/nucleotide analogues in the treatment of chronic hepatitis B
James Fung et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Risk factors for hepatocellular carcinoma in a cohort infected with hepatitis B or C
Scott R. Walter et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)
A TALE nuclease architecture for efficient genome editing
Jeffrey C. Miller et al.
NATURE BIOTECHNOLOGY (2011)
Expression of therapeutic proteins after delivery of chemically modified mRNA in mice
Michael S. D. Kormann et al.
NATURE BIOTECHNOLOGY (2011)
Protein expression from exogenous mRNA Uptake by receptor-mediated endocytosis and trafficking via the lysosomal pathway
Christina Lorenz et al.
RNA BIOLOGY (2011)
Hepatitis B viral load and risk for liver cirrhosis and hepatocellular carcinoma in The Gambia, West Africa
M. E. Mendy et al.
JOURNAL OF VIRAL HEPATITIS (2010)
Zinc-finger Nucleases as a Novel Therapeutic Strategy for Targeting Hepatitis B Virus DNAs
Thomas J. Cradick et al.
MOLECULAR THERAPY (2010)
Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based Mechanisms
Akin Akinc et al.
MOLECULAR THERAPY (2010)
The discovery of zinc fingers and their development for practical applications in gene regulation and genome manipulation
Aaron Klug
QUARTERLY REVIEWS OF BIOPHYSICS (2010)
CRISPR/Cas, the Immune System of Bacteria and Archaea
Philippe Horvath et al.
SCIENCE (2010)
Antiviral Treatment of Chronic Hepatitis B Virus (HBV) Infections
Erik De Clercq et al.
VIRUSES-BASEL (2010)
Expanding or Restricting the Target Site Repertoire of Zinc-finger Nucleases: The Inter-domain Linker as a Major Determinant of Target Site Selectivity
Eva-Maria Haendel et al.
MOLECULAR THERAPY (2009)
Breaking the Code of DNA Binding Specificity of TAL-Type III Effectors
Jens Boch et al.
SCIENCE (2009)
A Simple Cipher Governs DNA Recognition by TAL Effectors
Matthew J. Moscou et al.
SCIENCE (2009)
IFNα and IFNλ differ in their antiproliferative effects and duration of JAK/STAT signaling activity
Stephen G. Maher et al.
CANCER BIOLOGY & THERAPY (2008)
DNA-binding specificity is a major determinant of the activity and toxicity of zinc-finger Nucleases
Tatjana I. Cornu et al.
MOLECULAR THERAPY (2008)
Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability
Katalin Kariko et al.
MOLECULAR THERAPY (2008)
Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein
Joerg Petersen et al.
NATURE BIOTECHNOLOGY (2008)
Hepatitis B viruses: Reverse transcription a different way
Michael Nassal
VIRUS RESEARCH (2008)
Robust expansion of human hepatocytes in Fah-/-/Rag2-/-/Il2rg-/- mice
Hisaya Azuma et al.
NATURE BIOTECHNOLOGY (2007)
Assembly and budding of a hepatitis B virus is mediated by a novel type of intracellular vesicles
Mouna Mhamdi et al.
HEPATOLOGY (2007)
Hepatitis B virus replication
Juergen Beck et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Intracellular transport of hepatitis B virus
Michael Kann et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells
Silke Holtkamp et al.
BLOOD (2006)
An immunocompetent mouse model for the tolerance of human chronic hepatitis B virus infection
Li-Rung Huang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Hepatitis B virus reverse transcriptase and ε RNA sequences required for specific interaction in vitro
JM Hu et al.
JOURNAL OF VIROLOGY (2006)
Suppression of defense response in plants by the avrBs3/pthA gene family of Xanthomonas spp.
T Fujikawa et al.
MOLECULAR PLANT-MICROBE INTERACTIONS (2006)
mRNA transfection of dendritic cells:: Synergistic effect of ARCA mRNA capping with Poly(A) chains in cis and in trans for a high protein expression level
M Mockey et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Suppression of RNA recognition by Toll-like receptors:: The impact of nucleoside modification and the evolutionary origin of RNA
K Karikó et al.
IMMUNITY (2005)
Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis
A Akinc et al.
JOURNAL OF GENE MEDICINE (2005)
Molecular mechanisms in hepatocellular carcinoma development
C Cha et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2005)
Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein
P Gripon et al.
JOURNAL OF VIROLOGY (2005)
Novel cap analogs for in vitro synthesis of mRNAs with high translational efficiency
E Grudzien et al.
RNA (2004)
Messenger RNA turnover in eukaryotes: Pathways and enzymes
S Meyer et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2004)
Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy
B Werle-Lapostolle et al.
GASTROENTEROLOGY (2004)
Novel anti-reverse cap analogs with superior translational properties
J Jemielity et al.
RNA (2003)
An infectious clone of woolly monkey hepatitis B virus
RE Lanford et al.
JOURNAL OF VIROLOGY (2003)
Hydrodynamic injection of viral DNA: A mouse model of acute hepatitis B virus infection
PL Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Incidence and risk factors for acute hepatitis B in the United States, 1982-1998: Implications for vaccination programs
ST Goldstein et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Molecular mechanisms of translation initiation in eukaryotes
TV Pestova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
The cap-to-tail guide to mRNA turnover
CJ Wilusz et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)
Polyethylenimine-mediated gene delivery: a mechanistic study
A Kichler et al.
JOURNAL OF GENE MEDICINE (2001)
Decreased immunogenicity of recombinant hepatitis B vaccine in chronic hepatitis C
M Wiedmann et al.
HEPATOLOGY (2000)
分享论文
